Efficiency of a self-administered outpatient parenteral antimicrobial therapy (s-opat) for infective endocarditis within the context of a shortened hospital admission based on hospital at home program

References

• Cahill TJ, Prendergast BD. Infective endocarditis. Lancet. 2016;387:882–893.
   PubMed Web of Science ®Google Scholar
• Fernández-Hidalgo N, Tornos Mas P. Epidemiología de la endocarditis infecciosa en España en los últimos 20 años. Rev Esp Cardiol. 2013;66:728–733.
   PubMedGoogle Scholar
• Murdoch DR, Corey GR, Hoen B, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the international collaboration on endocarditis prospective cohort study. Arch Intern Med. 2009;169:463–473.
   PubMed Web of Science ®Google Scholar
• Muñoz P, Kestler M, De Alarcon A, et al. Current epidemiology and outcome of infective endocarditis: a multicenter, prospective, cohort study. Medicine. 2015;94(43):e1816.
   PubMed Web of Science ®Google Scholar
• Salleras Sanmartí L, Navas Alcalá E, Domínguez García A. Evaluación de la eficiencia de las intervenciones preventivas y de los programas de salud. In: Sierra-López A, eds. Piédrola Gil, Medicina Preventiva y Salud Pública, 11ª ed. Elsevier Másson, Barcelona; 2008. p. 1217–1230.
   Google Scholar
• Mirón-Rubio M1, González-Ramallo V2, Estrada-Cuxart O3, et al. Intravenous antimicrobial therapy in the hospital-at-home setting: data from the Spanish Outpatient Parenteral Antimicrobial Therapy Registry. Future Microbiol. 2016;11:375–390.
   PubMed Web of Science ®Google Scholar
• Barr DA, Semple L, Seaton RA. Outpatient parenteral antimicrobial therapy (OPAT) in a teaching hospital-based practice: a retrospective cohort study describing experience and evolution over 10 years. Int J Antimicrob Agents. 2012;39:407–413.
   PubMed Web of Science ®Google Scholar
• Tice AD, Rehm J, Dalovisio J, et al. Practice guidelines for outpatient parenteral antimicrobial therapy. Clin Infect Dis. 2004;38:1651–1672.
   PubMed Web of Science ®Google Scholar
• Matthews PC, Conlon CP, Berend AR, et al. Outpatient parenteral patients to self-administer at home? A retrospective analysis of a large cohort over 13 years. J Antimicrob Chemother. 2007;60:356–362
   PubMed Web of Science ®Google Scholar
• Martínez-González MA. Conceptos de salud pública y estrategias preventivas: un manual para ciencias de la salud. Madrid: Elsevier; 2013.
   Google Scholar
• Gonzalez Ramallo VJ, Bouza E. Home intravenous antimicrobial therapy. Med Clin (Barc). 2008;131:295–297.
   PubMed Web of Science ®Google Scholar
• Mendoza-Ruiz De Zuazu H, Casas Arrate J, De La Maza I, et al. Home intravenous antibiotic treatment: a study in 515 patients. Enfermedades Infecc Microbiol Clin. 2005;23:396–401.
   PubMed Web of Science ®Google Scholar
• Horcajada JP, Garcia L, Benito N, et al. Specialized home care for infectious disease. Experience from 1995 to 2002. Enferm Infecc Microbiol Clin. 2007;25:429–436.
   PubMed Web of Science ®Google Scholar
• Gonzalez Ramallo VJ, Segado-Soriano A. Twenty-five years of hospital at home in Spain. Med Clin. 2006;126:332–333.
   PubMed Web of Science ®Google Scholar
• Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the task force on the prevention, diagnosis, and treatment of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J. 2009;30:2369–2413.
   PubMed Web of Science ®Google Scholar
• Habib G, Lancellotti P, Antunes MJ, et al. Eur 2015 ESC Guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36:3075–3128.
   PubMed Web of Science ®Google Scholar
• Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on rheumatic fever, endocarditis, and kawasaki disease, council on cardiovascular disease in the young, and the councils on clinical cardiology, stroke, and cardiovascular surgery and anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation. 2005;111:e394–434.
   PubMed Web of Science ®Google Scholar
• Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, and the councils on clinical cardiology, stroke, and cardiovascular surgery and anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation. 2015;132:1435–1486.
   PubMed Web of Science ®Google Scholar
• Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633–638.
   PubMed Web of Science ®Google Scholar
• Pajarón M, Fernández-Miera MF, Allende I, et al. Hospital valdecilla endocarditis study group. Self-administered outpatient parenteral antimicrobial therapy (S-OPAT) for infective endocarditis: a safe and effective model. Eur J Intern Med. 2015;26:131–136.
   PubMed Web of Science ®Google Scholar
• Esposito S, Noviello S, Boccia G, et al. Changing modalities of outpatient parenteral antimicrobial therapy use over time in Italy: a comparison of two time periods. Infez Med. 2016;4(2):137–139.
   Google Scholar
• Chapman AL, Dixon S, Andrews D, et al. Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective. J Antimicrob Chemother. 2009;64:1316–1324.
   PubMed Web of Science ®Google Scholar
• MacKenzie M, Rae N, Nathwani D. Outcomes from global adult outpatient parenteral antimicrobial therapy programmes: a review of the last decade. Int Jantimicrob Agents. 2014 Jan;43:7–16.
   PubMed Web of Science ®Google Scholar
• Andrews MM, Von Reyn CF. Patient selection criteria and management guidelines for outpatient parenteral antibiotic therapy for native valve infective endocarditis. Clin Infect Dis. 2001;33:203–209.
   PubMed Web of Science ®Google Scholar
• Tice AD. Safety of outpatient parenteral antimicrobial therapy for endocarditis. Clin Infect Dis. 2002;34:419–420.
   PubMed Web of Science ®Google Scholar
• McMahon JH, O’Keeffe JM, Grayson ML. Is hospital-in-the-home (HITH) treatment of bacterial endocarditis safe and effective? Scand J Infect Dis. 2008;40:40–43.
   PubMed Web of Science ®Google Scholar
• Larioza J, Heung L, Girard A, et al. Management of infective endocarditis in outpatients: clinical experience with outpatient parenteral antibiotic therapy. South Med J. 2009;6:575–579.
   Google Scholar
• Amodeo MR. Outpatient intravenous treatment for infective endocarditis: safety, effectiveness and one-year outcomes. J Infect. 2009;59:387–393.
   PubMed Web of Science ®Google Scholar
• Cervera C, Del Rio A, Garcia L, et al. Efficacy and safety of outpatient parenteral antibiotic therapy for infective endocarditis: a ten-year prospective study. Enferm Infecc Microbiol Clin. 2011;29:587–592.
   PubMed Web of Science ®Google Scholar
• Partridge DG, O’Brien E, Chapman AL. Outpatient parenteral antibiotic therapy for infective endocarditis: a review of 4 years’ experience at a UK centre. Postgrad Med J. 2012;88:377–381.
   PubMed Web of Science ®Google Scholar
• Duncan CJ, Barr D, Ho A, et al. Risk factor for failure of outpatient parenteral therapy (OPAT) in infective endocarditis. J Antimicrob Chemother. 2013;68:1650–1654.
   PubMed Web of Science ®Google Scholar
• Paladino JA, Poretz D. Outpatient parenteral antimicrobial therapy today. Clin Infect Dis. 2010;51:198–208.
   PubMed Web of Science ®Google Scholar
• Lai A, Tran T, Nguyen HM, et al. Outpatient parenteral antimicrobial therapy at large veterans administration medical center. Am J Manag Care. 2013;19:317–324.
   PubMed Web of Science ®Google Scholar
• Wai AO, Frighetto L, Marra CA, et al. Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme. A Canadian teaching hospital and ministry of health perspective. Pharmacoeconomics. 2000;18:451–457.
   PubMed Web of Science ®Google Scholar
• Ruth CA, Parameswaran GI, Wojciechowski AL, et al. Outcomes and pharmacoeconomic analysis of a home intravenous antibiotic infusion program in veterans. Clin Ther. 2015;37:2527–2535.
   PubMed Web of Science ®Google Scholar
• Subedi S, Looke DF, McDougall DA, et al. Supervised self-administration of outpatient parenteral antibiotic therapy: a report from a large tertiary hospital in Australia. Int J Infect Dis. 2015;30:161–165.
   PubMed Web of Science ®Google Scholar
• Sunder S, Grammatico-Guillon L, Baron S, et al. Clinical and economic outcomes of infective endocarditis. Infect Dis (Lond). 2015;47:80–87.
   PubMed Web of Science ®Google Scholar
• Lacroix A, Revest M, Patrat-Delon S, et al. Outpatient parenteral antimicrobial therapy for infective endocarditis: a cost-effective strategy. Med Mal Infect. 2014;44:327–330.
   PubMed Web of Science ®Google Scholar